BioSpace News Archive

Why Life Science Tools? Life science tools refer to a range of equipment and technologies used in various scientific disciplines, including biology, chemistry, and medicine.

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated,

Epic Sciences, Inc. announced today that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (administered by Palmetto GBA) that provides coverage under the Medicare program for molecular diagnostic tests performed in our region.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results on Wednesday, May 3, 2023.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery as the standard of care in spine, has announced a leadership change and reorganization, as well as the sale of its Remi® Robotic Navigation System assets to Alphatec Holdings, Inc..

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced changes to the company’s Quality unit.

Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today presented two posters showcasing the latest preclinical data for the company’s lead oncology mRNA therapeutic, NTX-250, at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando, Fla. (April 14-19).

Zynex, Inc today announced that the company will report first quarter 2023 financial results on Thursday, April 27, 2023.

Tivic Health® Systems, Inc., a health tech company that develops and commercializes bioelectronic medicine, announced that it has expanded its post-operative pain clinical study to include Otolaryngology and Facial Plastic Surgery patients.

Ancora Heart, Inc. and egnite, Inc. today announced a strategic partnership to accelerate clinical trial enrollment for Ancora Heart’s CORCINCH-HF pivotal clinical trial, which is evaluating the safety and efficacy of the AccuCinch® Ventricular Restoration System.